About CDx Diagnostics
CDx Diagnostics is a Healthcare company based in Suffern (United States) founded in 1997 by Mark Rutenberg, and was acquired by Galen Partners in July 2017. AI-based platform is utilized to detect precancerous tissues in biopsies. It operates in the Healthcare and Technology sectors. CDx Diagnostics has raised $16.04 million across 2 funding rounds from investors including Galen Partners. CDx Diagnostics offers products and services including WATS 3D, OralCDx, and EndoCDx. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Precision Medicine. Its competitors include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
CDx Diagnostics was founded in 1997 and is headquartered in Suffern, United States. The company operates in the healthcare diagnostics sector, focusing on AI-driven technologies for early detection of precancerous conditions. Proprietary WATS3D biopsy platform is employed to identify tissue changes. Key products include OralCDx, a non-invasive oral brush biopsy system, and EndoCDx, a transepithelial laryngeal brush biopsy tool, supporting clinical assessments in oncology-related fields.
- Headquarters Suffern, United States
- Founders Mark Rutenberg
- Stage Acquired
- SectorsHealthcareTechnology
- Phone•••• ••••
- Website cdxdiagnostics.com
- Social LinkedIn X Facebook YouTube
- Acquired by Galen Partners (Jul 2017)
- Total Equity Funding$16.04M (USD)
in 2 rounds
- Latest Funding Round$5M (USD), Series A
Jun 2020
- Investors
- Acquired byGalen Partners
(Jul 2017)
Products & Services of CDx Diagnostics
CDx Diagnostics offers a comprehensive portfolio of products and services, including WATS 3D, OralCDx, and EndoCDx.
AI-enabled tool for early detection of precancerous cells in esophagus.
Platform for oral cancer prevention through advanced tissue analysis.
Technology for detecting dysplasia in endoscopic procedures.
Apps and channels of CDx Diagnostics
its YouTube channel WATS3D has 7 subscribers and 11 videos.
Videos from CDx Diagnostics
The most watched videos on CDx Diagnostics's YouTube channel, WATS3D (7 subscribers). Click a video to play it here.
More on WATS3D.
Funding Insights of CDx Diagnostics
CDx Diagnostics has successfully raised a total of $16.04M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.04M
- Total Rounds 2
- Last Round Series A — $5M
- First Round $11.04M
(Dec 2019)
All 2 funding rounds of CDx Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2020 | $5M | Series A | – | – | – |
| Dec 2019 | $11.04M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in CDx Diagnostics
CDx Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Galen Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in the US | galen.com | Stamford, United States |
Investor details for CDx Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CDx Diagnostics
22 people are tracked at CDx Diagnostics (6 in leadership, 4 in board & advisors, 12 in team).
| Name | Role | Group |
|---|---|---|
Mark Rutenberg | Founder | Leadership |
Tom Bartel | Executive Vice President Of Sales | Leadership |
Bonnie Pirtz | Senior Vice President, Market Access & Reimbursement | Leadership |
Robert Tjon | VP of Engineering | Leadership |
Patricia Romano | Laboratory Director | Leadership |
Karen Hoffman | Director Of Research | Leadership |
Thomas A. Bologna | Chairman | Board & advisors |
John Watts | Director | Board & advisors |
David Jahns | Director | Board & advisors |
Michael D. Bacon | Director | Board & advisors |
Amanda Perello | Senior Manager, IT Applications Management | Team |
Jonathan Justin | Talent Acquisition Lead | Team |
Roger O'Sullivan | General Counsel, Corporate Secretary, Compliance Officer | Team |
Ramesh Ramasamy | SVP, Technology | Team |
Deborah Sherman | Senior Accountant | Team |
Samantha Hippler | Client Services Team Lead | Team |
Sheila Mosley | Laboratory Operations Manager | Team |
Marisol Padilla | Data Applications Specialist | Team |
Daniela Ducasse | Senior Credentialing Specialist | Team |
Stephen Frist M.D. | Consultant Research Pathologist - Computer Assisted Surgical Pathology And Cytology | Team |
2 more people are available in the full profile.
Complete people profiles for CDx Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CDx Diagnostics
4 dated milestones of CDx Diagnostics across 23 years, from founding to its latest funding, stage changes and deals.
- Founded CDx Diagnostics is founded.
- Exit Acquired by Galen Partners.
- Funding First funding round of $11.0M.
- Funding Latest funding round, Series A, of $5.0M.
Competitors of CDx Diagnostics
CDx Diagnostics has 3 listed competitors in our database, 3 of them funded. They include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. |
Detailed competitors of CDx Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CDx Diagnostics
The website of CDx Diagnostics (cdxdiagnostics.com) receives about 2.6K visits a month.
- Monthly visits2.6K
▼ 15.9% vs previous month
Top companies in Clinical Genomics
3 companies that operate in the same segment as CDx Diagnostics (Clinical Genomics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cdx Diagnostics
Complete news archive for CDx Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CDx Diagnostics
CDx Diagnostics was founded in 1997 and raised its 1st funding round 22 years after it was founded.
CDx Diagnostics is headquartered in Suffern, United States. It is registered at Suffern, New York, United States.
CDx Diagnostics is a funded company, having raised a total of $16.04M across 2 funding rounds to date. The company's 1st funding round was a Series A of $11.04M, raised on Dec 2019.
CDx Diagnostics was founded in 1997 and is headquartered in Suffern, United States. The company operates in the healthcare diagnostics sector, focusing on AI-driven technologies for early detection of precancerous conditions. Proprietary WATS3D biopsy platform is employed to identify tissue changes. Key products include OralCDx, a non-invasive oral brush biopsy system, and EndoCDx, a transepithelial laryngeal brush biopsy tool, supporting clinical assessments in oncology-related fields.
CDx Diagnostics's top competitors include Poseida Therapeutics, Denali Therapeutics and Castle Biosciences.
CDx Diagnostics offers WATS 3D, OralCDx, and EndoCDx.
CDx Diagnostics has 1 investor. Key investors include Galen Partners.
Yes. CDx Diagnostics was acquired by Galen Partners in July 2017.

